Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. (Q54734887)

3 June 2018

title

Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. (English)

1 reference

3 June 2018

author name string

Katherine V Clark-Knowles

1

1 reference

3 June 2018

Kenneth Garson

2

1 reference

3 June 2018

Jos Jonkers

3

1 reference

3 June 2018

Barbara C Vanderhyden

4

1 reference

3 June 2018

language of work or name

English

0 references

publication date

3 October 2006

1 reference

3 June 2018

Experimental Cell Research

published in

1 reference

3 June 2018

volume

313

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

133-145

1 reference

3 June 2018

Ovarian surface epithelium: biology, endocrinology, and pathology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

E-cadherin expression in human epithelial ovarian cancer and normal ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Prophylactic oophorectomy: a morphologic and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

BRCA1 is a cell cycle-regulated nuclear phosphoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Frequency of BRCA1 dysfunction in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Caretaker Brca1: keeping the genome in the straight and narrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Induction of ovarian cancer by defined multiple genetic changes in a mouse model system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

p53 protein expression in putative precursor lesions of epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Ovarian carcinogenesis and the biology of ovarian surface epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotes

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

inferred from DOI database lookup

7 January 2021

based on heuristic

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.09.026

10.1016/J.YEXCR.2006.09.026

7 January 2021

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018